This is the first video game that is prescribed as a medicine


Despite the passage of the years, and the fall of some other myth malientencionado, video games continue to not be recognized by many as a cultural product. Nor as something that can help you overcome a bad time or, even, a disease. At least, until now. The FDA (Federation of Drug and Food of the united States, for its acronym in English) has decided to approve the prescription of a video game intended for the treatment of the disorder attention deficit hyperactivity disorder (ADHD) in children between 8 and 12 years.

The video game in question is the “EndeavorRX”. Developed by the company Akili, it is a racing title in which the user has to go dodging various obstacles along the way. A mechanic that, as you know the regular users, forces you to pay more attention than usual to the screen.

“EndeavorRx offers a non-pharmacological way to improve symptoms associated with ADHD in children, and is an important example of the growing field of therapy and digital therapeutics digital,” he explained in a press release, Jeffrey Shuren, director of the Center for Devices of FDA.

From Akili point that the video game is especially designed to directly activate neural systems by the presentation of sensory stimuli and challenges engines. To be recognized as a treatment against ADHD, the title was subjected to five clinical studies that involved more than 600 children with this disorder.

“Families are looking for new ways to help their children with ADHD. With the decision today of the FDA, we are excited to offer families an option of treatment without medications pioneer assumed, in addition, a first important step towards our goal of helping all people who suffer from cognitive problems,” he said in another statement Eddie Martucci, executive director of Akili.

Also, from the company indicate that the use of this video game it is a section within a treatment. It will be available with a prescription for american families shortly. .


About Author

Leave A Reply